
Hari Sankaran
Pediatric Hematology Oncology
111 Michigan Avenue Northwest
Washington, DC 20010
Washington, DC 20010
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Associations of Age With Tumor Genomic Characteristics in Relapsed/Refractory Cancers Interrogated With the NCI-MATCH Trial Targeted Gene Panel Assay.
Journal: JCO precision oncology
Published: August 07, 2026
Unique Challenges in Sarcoma Care for Adolescents and Young Adults.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 04, 2026
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results.
Journal: Journal for immunotherapy of cancer
Published: May 21, 2026
Serum microRNA Profiles Reflect Differentiation Status and Age in Early Gastric Cancer.
Journal: Biomolecules
Published: May 07, 2026
Risk of developing malignant peripheral nerve sheath tumors in patients with neurofibromatosis 1 receiving MEK inhibitor treatment for plexiform neurofibromas.
Journal: Neuro-oncology advances
Published: April 28, 2026
Endothelial activation and stress index score as a predictor of transplant-associated thrombotic microangiopathy in patients with sickle cell disease.
Journal: British journal of haematology
Published: November 21, 2025
Risk Factors for COVID-19-Related Hospitalization and Death in Patients With Cancer: The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS).
Journal: JAMA oncology
Published: July 17, 2025
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.
Journal: Nature medicine
Published: March 19, 2024
Clinical trials for chimeric antigen receptor T-cell therapy: lessons learned and future directions.
Clinical trials for chimeric antigen receptor T-cell therapy: lessons learned and future directions.
Journal: Current opinion in hematology
Published: July 05, 2022
Can 18 F-FDG-Positron Emission Tomography be a Prognostic Tool in Children With Rhabdomyosarcoma Treated With Definitive Radiotherapy?
Journal: Journal of pediatric hematology/oncology
Published: March 27, 2022
Last Updated: 09/26/2026